Work

0738 Oveporexton (TAK-861) Improves Cognitive Symptoms in Patients with Narcolepsy Type 1: Results from Two Randomized, Placebo-controlled Phase 3 Trials

Year: 2026

Type: conference-abstract

Source: SLEEP

DOI: 10.1093/sleep/zsag091.0737

Authors: Fabio Pizza, Yves Dauvilliers, Rafael Del Rio Villegas, Emmanuel Mignot, Thomas Scammell, Tathagata Banerjee, Alice Cai, Mark Etherton, Ellie Stukalin, Vahe Khachadourian, Paul Maruff, Tina Olsson, Robert Pietrzak, Dmitri Volfson, Brian Harel

Institutions: University of Bologna, Hôpital Gui de Chauliac, Stanford Medicine, Stanford University, Boston Children's Hospital, Beth Israel Deaconess Medical Center, Takeda (United States), Yale University

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160660391

Cites:

Cited by: 1

Related to: